Two important concepts that help with this are the Value at Risk (VaR) Margin and Extreme Loss Margin (ELM).

The shares of the company have an ROE of 95 per cent and an ROCE of 117 per cent.

Regulatory changes, such as the US Biosecure Act, may accelerate growth for CDMO businesses. However, uncertainties remain, especially if Donald Trump returns to power. Trump has criticized India on trade issues, including pharmaceutical tariffs, which could impact domestic pharma strategies.

There are specific sessions, called Pre-Open Sessions and Special Pre-Open Sessions, that occur before the official market hours.

Small Finance Bank Shares in Focus After Approval to Sell Rs 364.51 Crore Micro Banking Loan Pool

The company has a market cap of over Rs 300 crore and stock is up by 24 per cent from its 52-week low of Rs 212.20 per share.

Media Reports Indicate the Deal Follows RBI’s Recent Lifting of Curbs on Asirwad Micro Finance

The company has a market cap of Rs 183 crore and stock is trading below Rs 85 on NSE.

The stock is up by 18 per cent from its 52-week low of Rs 78 per share.

About 1,209 shares have advanced, 2,809 shares have declined and 182 shares were unchanged on BSE.

The market breadth was heavily skewed towards declines, with 775 advances and 2,097 declines, indicating widespread bearish sentiment among investors at the closing bell.

The stock is up by 40 per cent from its 52-week low of Rs 171.40 per share.

This situation echoes the economic challenges of the 1970s and suggests that investors should brace for potential market volatility.

While it might seem complicated, it's actually quite simple.

The Company Receives Establishment Inspection Report (EIR) from the U.S. FDA for Its Manufacturing Facility in Somerset, New Jersey

The company has a market cap of Rs 8,230 crore and has a good return on equity (ROE) track record: 3 Years ROE 30.6 per cent.

Market breadth remained strongly negative, with 680 advances and 2,050 declines, underscoring the pervasive bearish sentiment prevailing among investors.

The Bombay Stock Exchange (BSE), one of Asia’s oldest stock exchanges, categorizes listed companies into different groups based on market capitalization, trading volumes, compliance, and other factors.

The stock is up by 11 per cent from its 52-week low of Rs 285.20 per share and gave multibagger returns of 240 per cent in 3 years.

KKR, a leading global investment firm, has acquired a controlling stake in Indian Cancer Care Hospital from CVC Capital Partners for Rs 3,466 crore, strengthening its presence in the healthcare sector.

It works like borrowing money from your broker to invest in the stock market. While this can help you earn bigger profits, it also comes with higher risks.

The stock is up by 11.3 per cent from its 52-week low of Rs 292.75 per share and gave multibagger returns of 165 per cent in 3 years.

Market breadth remains heavily negative, with 753 advances and 1,955 declines, indicating continued negative sentiment among investors.

Company's Board Approves Marketing and Supply Agreement with Mylan Pharmaceuticals

The stock is up by 16 per cent from its 52-week low of Rs 16.54 per share and gave multibagger returns of over 1,800 per cent in 5 years. 

The stock is up by 5.7 per cent from its 52-week low of Rs 349.2 per share and gave multibagger returns of 145 per cent in 3 years.

The stock remains around 25 per cent below its 52-week high of Rs 511 on the BSE, indicating potential upside if market sentiment improves.

The stock gave multibagger returns of 475 per cent in just 2 years and a whopping 1,500 per cent in 5 years.

The stock gave multibagger returns of 200 per cent in just 1 year and a whopping 9,850 per cent in 3 years.

The stock gave multibagger returns of 1,300 per cent in 5 years and a whopping 3,200 per cent in a decade.

Market breadth is heavily negative, with 323 advances and 2066 declines, indicating negative sentiment prevailing among investors.

The stock is up by 58 per cent from its 52-week low of Rs 28.41 per share.

GIFT Nifty suggested a weak start for Indian equities. As of 07:00 AM IST, Nifty futures were trading at 22,684, reflecting bearish sentiment in the market.

Broader markets sink, volatility eases, and sectoral losses deepen as investor sentiment turns negative.

Second Nashik Unit to Boost Production by 33,000 MT Annually

Company secures a major contract while battling declining profits and project delays

Company has been a stellar performer in the stock market, with its stock price soaring 121.23 per cent in the past year, significantly outperforming the Nifty’s 3.28 per cent rise during the same period.

Market breadth is negative, with 1,245 advances and 1,462 declines, indicating negative sentiment prevailing among investors.

A top mortgage lender partners with IBM to modernize operations—will this fuel its stock growth?

Over a five-year period, the stock has delivered an impressive 334.2 per cent return to its investors.

A major online travel platform partners with Korea Tourism to boost Indian tourism—what it means for investors!

A strategic move reshapes the online gaming industry with a multi-crore acquisition and merger plan.

Market breadth is strongly negative, with 961 advances and 1,656 declines, indicating negative sentiment prevailing among investors.

With this buyout, the company aims to accelerate its position in cloud and automation.

Steel Leader Expands into Copper & Brass with 200MT/Month Production at New Facility

Market breadth is slightly positive, with 1,735 advances and 702 declines, indicating mixed sentiment prevailing among investors.

The GIFT Nifty signaled a slightly negative start for Indian equities. At 7:00 AM IST, Nifty futures were trading at 22,852, down 0.24 per cent.

Largest Single Order of CY25! This Defence Stock Bags a Massive Deal – Do You Hold It?

Recommendations Based on Street Talk 

Technical Analysis of 1 stock (with 15-day horizon)

This indicator measures the percentage of Nifty 50 stocks that are trading above/below their 200-day simple moving averages.

Review of 1 stock recommended in the past

1 stock recommendation each based on Fundamental and Technical analysis along with timely review to provide you with handsome profits.

Expert guidance to subscribers queries on stocks held by them.

The markets are known for their cycles of ups and downs, and while every downturn feels relentless

Strategic US Investment to Strengthen UAV and Robotics Capabilities

Leading London Brokerage Adopts AI for Smarter Risk Assessment

Major MoU Signed to Boost Green Hydrogen Development

Seeing how mutual funds are finding their rightful place in investors’ portfolios is heartening.

Every fortnight, we recommend one open-ended equity diversified fund that has the best potential of returns for the next one year considering its constituents remain the same.

Market breadth was positive, with 1,998 advances and 830 declines, indicating positive sentiment prevailing among investors.

March 31st is the cut-off date to complete tax saving investments every financial year and with less than 90 days left to close our books of accounts, now is the time to minimise your tax liability.

Cholamandalam Investment and Finance Company Limited is not only on an expanding spree, both geographically and with the introduction of new product lines, but is also leveraging technology to improve its functioning across the country. Excerpts from an interview with the company’s President and CFO Arul Selvan

Mutual funds have transformed from a niche product to a ₹68 lakh crore ecosystem empowering millions. The formula for success is simple: Start early, invest regularly, diversify strategically, and ignore short-term noise. The article brings into the limelight the role that mutual funds can play in your investment journey 

a financial creditor, decided to withdraw its insolvency petition against the company after negotiating a One-Time Settlement (OTS). The NCLT allowed the withdrawal but here's a catch 

Laurus Labs has showcased impressive growth in the custom synthesis and FDF segments

The Indian market has been facing a severe downturn for the past few months.

The recommendations provided in this column are taken from various market sources such as brokers, analysts, dealers and investment strategists, etc. These recommendations may not be backed by strong fundamentals. Therefore we advise readers to use their own discretion before investing in these recommendation 

The Indian rupee has been on a consistent decline against the U.S. dollar since Donald Trump won the U.S. presidential election.

Stock Trading at Low P/E with Strong Future Prospects

Company has secured a large order from Aditya Birla Group company for the construction of an 850 KTPA (kilo tonne per annum) greenfield alumina refinery plant in Odisha.

Government Partnership to Drive MSME Growth

The recent spike in SIP stoppages, with a discontinuation ratio of 109 per cent in January 2025, has raised concerns among mutual fund investors.

The scrips in this column have been recommended with a 15-day investment horizon in mind and carry high risk. Therefore, investors are advised to take into account their risk appetite before investing, as fundamentals may or may not back the recommendations.

The Indian markets have faced a challenging phase since October 2024, with the Nifty 50 breaking a 23-year record by marking its fourth consecutive month of decline.

This section gives a recommendation of a stock having stock price below Rs 150 with sound fundamentals and expected to give handsome returns over a one-year time horizon.

Market breadth is positive, with 1,933 advances and 788 declines, indicating positive sentiment prevailing among investors.

This column gives you scrip chosen by the research team during the fortnight that is fundamentally strong and expected to give good capital appreciation over a time period of 1 year.

The New Income Tax Bill 2025 was tabled in the Lok Sabha after Finance Minister Nirmala Sitharaman proposed complete Income Tax exemption

I have been interested in metal stocks, but recent declines

Big Government Deals Make This Stock a Strong Contender for Growth

Massive Solar Module Order Secured for 362.5 MWp